Skip to main content
Top
Published in: Gastric Cancer 2/2016

01-04-2016 | Original Article

Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancers for magnifying endoscopy with narrow-band imaging: endoscopic submucosal dissection cases

Authors: Yusuke Horiuchi, Junko Fujisaki, Noriko Yamamoto, Tomoki Shimizu, Yuji Miyamoto, Hideomi Tomida, Masami Omae, Akiyoshi Ishiyama, Toshiyuki Yoshio, Toshiaki Hirasawa, Yorimasa Yamamoto, Tomohiro Tsuchida, Masahiro Igarashi, Hiroshi Takahashi

Published in: Gastric Cancer | Issue 2/2016

Login to get access

Abstract

Background

The usefulness of magnifying endoscopy with narrow-band imaging (ME-NBI) for undifferentiated-type early gastric cancers (UD-type EGCs) is unclear. The present study examined the accuracy of the diagnostic demarcation of lesions using ME-NBI.

Methods

The study population consisted of 76 patients with UD-type EGC lesions measuring ≤20 mm in diameter using white-light imaging (WLI) and endoscopic ultrasonography and diagnosed as intramucosa and UL(−); all the lesions were confirmed as early gastric cancer based on postoperative pathological examination. All the patients had undergone an initial endoscopic submucosal dissection (ESD) at this hospital between January 2010 and January 2014. After marking with demarcation lines at the utmost oral and anal sites of the lesion using argon plasma coagulation under ME-NBI for intervention, the cases with demarcations that were consistent with the postoperative pathological findings were defined as having been accurately diagnosed. The inflammatory cell infiltration (Updated Sydney System, USS) were also assessed.

Results

The diagnostic demarcations of the lesion were consistent in 62 cases (81.6 %). The accurate diagnosis rate was higher for the USS cases with mild neutrophil and monocyte infiltration (P < 0.05). The addition of ME-NBI to WLI improved the accurate diagnosis rate by 27.6 %.

Conclusion

The use of ME-NBI in diagnostic demarcation of UD-type EGCs is recommended.
Literature
1.
go back to reference Japanese gastric cancer treatment guidelines. Japanese Gastric Cancer Association (ver. 3). Gastric Cancer. 2010;2011(14):113–23. Japanese gastric cancer treatment guidelines. Japanese Gastric Cancer Association (ver. 3). Gastric Cancer. 2010;2011(14):113–23.
2.
go back to reference Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;4:219–25.CrossRef Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;4:219–25.CrossRef
3.
go back to reference Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.CrossRefPubMed Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda Taniguchi H, et al. Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer. 2009;12:148–52.CrossRefPubMed
4.
go back to reference Yao K, Iwashita A, Tanabe H, Nagahama T, Matsui T, Ueki T, et al. Novel zoom endoscopy technique for diagnosis of small flat gastric cancer: a prospective, blind study. Clin Gastroenterol Hepatol. 2007;5:869–78.CrossRefPubMed Yao K, Iwashita A, Tanabe H, Nagahama T, Matsui T, Ueki T, et al. Novel zoom endoscopy technique for diagnosis of small flat gastric cancer: a prospective, blind study. Clin Gastroenterol Hepatol. 2007;5:869–78.CrossRefPubMed
5.
go back to reference Yao K, Iwashita A, Kikuchi Y, Yao T, Matsui T, Tanabe H, et al. Novel zoom endoscopy technique for visualizing the microvascular architecture in gastric mucosa. Clin Gastroenterol Hepatol. 2005;7:S23–6.CrossRef Yao K, Iwashita A, Kikuchi Y, Yao T, Matsui T, Tanabe H, et al. Novel zoom endoscopy technique for visualizing the microvascular architecture in gastric mucosa. Clin Gastroenterol Hepatol. 2005;7:S23–6.CrossRef
6.
go back to reference Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;5:462–7.CrossRef Yao K, Anagnostopoulos GK, Ragunath K. Magnifying endoscopy for diagnosing and delineating early gastric cancer. Endoscopy. 2009;5:462–7.CrossRef
7.
go back to reference Ninomiya Y, Yanagisawa A, Kato Y, Tomimatsu H. Unrecognizable intramucosal spread of diffuse-type mucosal gastric carcinomas of less than 20 mm in size. Endoscopy. 2000;8:604–8.CrossRef Ninomiya Y, Yanagisawa A, Kato Y, Tomimatsu H. Unrecognizable intramucosal spread of diffuse-type mucosal gastric carcinomas of less than 20 mm in size. Endoscopy. 2000;8:604–8.CrossRef
8.
go back to reference Nakayoshi T, Tajiri H, Matsuda K, Kaise M, Ikegami M, Sasaki H, et al. Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video). Endoscopy. 2004;12:1080–4.CrossRef Nakayoshi T, Tajiri H, Matsuda K, Kaise M, Ikegami M, Sasaki H, et al. Magnifying endoscopy combined with narrow band imaging system for early gastric cancer: correlation of vascular pattern with histopathology (including video). Endoscopy. 2004;12:1080–4.CrossRef
9.
go back to reference Okada K, Fujisaki J, Kasuga A, Omae M, Hirasawa T, Ishiyama A, et al. Diagnosis of undifferentiated-type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2011;26:1262–9.CrossRefPubMed Okada K, Fujisaki J, Kasuga A, Omae M, Hirasawa T, Ishiyama A, et al. Diagnosis of undifferentiated-type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2011;26:1262–9.CrossRefPubMed
10.
go back to reference Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The Updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The Updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.CrossRefPubMed
11.
go back to reference Kamada K, Tomatsuri N, Yoshida N. Endoscopic submucosal dissection for undifferentiated early gastric cancer as the expanded indication lesion. Digestion. 2012;85:111–5.CrossRefPubMed Kamada K, Tomatsuri N, Yoshida N. Endoscopic submucosal dissection for undifferentiated early gastric cancer as the expanded indication lesion. Digestion. 2012;85:111–5.CrossRefPubMed
12.
go back to reference Okada K, Fujisaki J, Yoshida T, Ishikawa H, Suganuma T, Kasuga A, et al. Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endoscopy. 2012;44:122–7.CrossRefPubMed Okada K, Fujisaki J, Yoshida T, Ishikawa H, Suganuma T, Kasuga A, et al. Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endoscopy. 2012;44:122–7.CrossRefPubMed
13.
go back to reference Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Odagaki T, et al. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy. 2013;45:703–7.CrossRefPubMed Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Odagaki T, et al. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy. 2013;45:703–7.CrossRefPubMed
14.
go back to reference Yamamoto Y, Fujisaki J, Hirasawa T, Ishiyama A, Yoshimoto K, Ueki N, et al. Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 mm or less in diameter. Dig Endosc. 2010;22:112–8.CrossRefPubMed Yamamoto Y, Fujisaki J, Hirasawa T, Ishiyama A, Yoshimoto K, Ueki N, et al. Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 mm or less in diameter. Dig Endosc. 2010;22:112–8.CrossRefPubMed
15.
go back to reference Kim YY, Jeon SW, Kim J, Park JC, Cho KB, Park KS, et al. Endoscopic submucosal dissection for early gastric cancer with undifferentiated histology: could we extend the criteria beyond? Surg Endosc. 2013;12:4656–62.CrossRef Kim YY, Jeon SW, Kim J, Park JC, Cho KB, Park KS, et al. Endoscopic submucosal dissection for early gastric cancer with undifferentiated histology: could we extend the criteria beyond? Surg Endosc. 2013;12:4656–62.CrossRef
16.
go back to reference Kang HY, Kim SG, Kim JS, Jung HC, Song IS. Clinical outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Surg Endosc. 2010;24:509–16.CrossRefPubMed Kang HY, Kim SG, Kim JS, Jung HC, Song IS. Clinical outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Surg Endosc. 2010;24:509–16.CrossRefPubMed
17.
go back to reference Kim JH, Lee YC, Kim H, Song KH, Lee SK, Cheon JH, et al. Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc. 2009;69:e1–9.CrossRefPubMed Kim JH, Lee YC, Kim H, Song KH, Lee SK, Cheon JH, et al. Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc. 2009;69:e1–9.CrossRefPubMed
18.
go back to reference Park YD, Chung YJ, Chung HY, Yu W, Bae HI, Jeon SW, et al. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach. Endoscopy. 2008;40:7–10.CrossRefPubMed Park YD, Chung YJ, Chung HY, Yu W, Bae HI, Jeon SW, et al. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach. Endoscopy. 2008;40:7–10.CrossRefPubMed
19.
go back to reference Yamaguchi N, Isomoto H, Fukuda E, Ikeda K, Nishiyama H, Akiyama M, et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer by indication criteria. Digestion. 2009;80:173–81.CrossRefPubMed Yamaguchi N, Isomoto H, Fukuda E, Ikeda K, Nishiyama H, Akiyama M, et al. Clinical outcomes of endoscopic submucosal dissection for early gastric cancer by indication criteria. Digestion. 2009;80:173–81.CrossRefPubMed
20.
go back to reference Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.CrossRefPubMed Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.CrossRefPubMed
21.
go back to reference Ito M, Tanaka S, Takata S, Oka S, Imagawa S, Ueda H, et al. Morphological changes in human gastric tumors after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther. 2005;21:559–66.CrossRefPubMed Ito M, Tanaka S, Takata S, Oka S, Imagawa S, Ueda H, et al. Morphological changes in human gastric tumors after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther. 2005;21:559–66.CrossRefPubMed
22.
go back to reference Tanaka A, Kamada T, Inoue K, Shiotani A, Kusunoki H, Manabe N, et al. Histological evaluation of patients with gastritis at the high risk of developing gastric cancer using a conventional index. Pathol Res Pract. 2011;207:354–8.CrossRefPubMed Tanaka A, Kamada T, Inoue K, Shiotani A, Kusunoki H, Manabe N, et al. Histological evaluation of patients with gastritis at the high risk of developing gastric cancer using a conventional index. Pathol Res Pract. 2011;207:354–8.CrossRefPubMed
Metadata
Title
Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancers for magnifying endoscopy with narrow-band imaging: endoscopic submucosal dissection cases
Authors
Yusuke Horiuchi
Junko Fujisaki
Noriko Yamamoto
Tomoki Shimizu
Yuji Miyamoto
Hideomi Tomida
Masami Omae
Akiyoshi Ishiyama
Toshiyuki Yoshio
Toshiaki Hirasawa
Yorimasa Yamamoto
Tomohiro Tsuchida
Masahiro Igarashi
Hiroshi Takahashi
Publication date
01-04-2016
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 2/2016
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-015-0488-x

Other articles of this Issue 2/2016

Gastric Cancer 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.